A novel high-throughput screening service that
delivers information previously difficult to access.


XRpro® provides HTS services yielding high Z’, with excellent reproducibility— helping you to make critical decisions faster and contributing to the effectiveness and efficiency of your drug discovery program. Our proprietary technology complements existing methodologies, making previously difficult measurements easily achievable.

XRpro® technology has broad applications—including interrogating live cells—and is compatible with standard lab automation. Whether you need HTS solutions for target validation, lead optimization, hERG, or assay development, XRpro® is the right partner.

On the Scene

XRpro at Discovery on Target 2014

Nathan Zahler, Ph.D., XRpro® Senior Scientist and Product Manager, presented on Oct. 8th, “Novel Strategies for Developing Functional Transporter and Ion Channel Assays.” 

Request a copy of the presentation.

Explore the Advantages

To discuss how XRpro® can contribute to your drug discovery program, contact us today.

Broad Insitute Collaboration

We are proud to have a research collaboration with the Broad Institute of Harvard and MIT.